SE7612295L - ANTIBIOTIC - Google Patents

ANTIBIOTIC

Info

Publication number
SE7612295L
SE7612295L SE7612295A SE7612295A SE7612295L SE 7612295 L SE7612295 L SE 7612295L SE 7612295 A SE7612295 A SE 7612295A SE 7612295 A SE7612295 A SE 7612295A SE 7612295 L SE7612295 L SE 7612295L
Authority
SE
Sweden
Prior art keywords
deacetyl
antibiotics
gram
thienamycin
antibiotic
Prior art date
Application number
SE7612295A
Other languages
Swedish (sv)
Inventor
J S Kahan
F M Kahan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612295L publication Critical patent/SE7612295L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Thienamycin of the structural formula I or its isomer called compound 890 A1 or 890 A3 is contacted with an amidohydrolase which is able to hydrolyse the N-acetyl group. The process for the preparation of the antibiotic thienamycin also makes it possible to prepare the antibiotics deacetyl-890 A1 and deacetyl-890 A3. These antibiotics have a very broad spectrum of action and are highly effective against both Gram-negative and Gram-positive microorganisms. They are suitable for use in human and veterinary medicine and for industrial purposes. <IMAGE>
SE7612295A 1975-11-24 1976-11-04 ANTIBIOTIC SE7612295L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63456075A 1975-11-24 1975-11-24

Publications (1)

Publication Number Publication Date
SE7612295L true SE7612295L (en) 1977-05-25

Family

ID=24544292

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612295A SE7612295L (en) 1975-11-24 1976-11-04 ANTIBIOTIC

Country Status (16)

Country Link
JP (1) JPS5265295A (en)
AR (1) AR224224A1 (en)
AU (1) AU510252B2 (en)
BE (1) BE848349A (en)
CH (1) CH625803A5 (en)
DE (1) DE2652678A1 (en)
DK (1) DK497476A (en)
ES (1) ES453508A1 (en)
FR (1) FR2351979A1 (en)
GB (1) GB1561108A (en)
GR (1) GR61407B (en)
HU (1) HU175266B (en)
NL (1) NL7612932A (en)
PT (1) PT65845B (en)
SE (1) SE7612295L (en)
ZA (1) ZA766986B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7800958A (en) * 1977-02-11 1978-08-15 Merck & Co Inc ANTIBIOTIC DESACETYL-DIHYDRO 890 A9, METHOD FOR PREPARING IT AND PHARMACEUTICAL PREPARATION CONTAINING THIS ANTIBIOTIC.
SE7800978L (en) * 1977-02-11 1978-08-12 Merck & Co Inc ANTIBIOTIC
US4162193A (en) * 1977-08-19 1979-07-24 Merck & Co., Inc. Enzymatic cleavage of N-acyl-thienamycins
PH16708A (en) 1978-07-24 1984-01-20 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
ATE4224T1 (en) * 1979-08-28 1983-08-15 Merck & Co. Inc. PROCEDURE FOR PURIFICATION OF THIENAMYCIN.
DE3146190A1 (en) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt INSULATION OF CHEMICALLY UNSTABLE ANTIBIOTICS FROM FERMENTATION SOLUTIONS
US10695322B2 (en) 2016-01-29 2020-06-30 The Johns Hopkins University Inhibitors of bacterial growth

Also Published As

Publication number Publication date
JPS5265295A (en) 1977-05-30
AU510252B2 (en) 1980-06-19
ES453508A1 (en) 1978-03-01
CH625803A5 (en) 1981-10-15
BE848349A (en) 1977-05-16
FR2351979B1 (en) 1982-08-13
HU175266B (en) 1980-06-28
GB1561108A (en) 1980-02-13
ZA766986B (en) 1978-06-28
AR224224A1 (en) 1981-11-13
DK497476A (en) 1977-05-25
AU1964576A (en) 1978-05-25
DE2652678A1 (en) 1977-06-02
PT65845A (en) 1976-12-01
NL7612932A (en) 1977-05-26
PT65845B (en) 1978-10-10
FR2351979A1 (en) 1977-12-16
GR61407B (en) 1978-11-11

Similar Documents

Publication Publication Date Title
ES477591A1 (en) Cephem derivatives
ES480915A1 (en) (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate and salts thereof
SE7902954L (en) THIAZOLYLETIC ACID ASSOCIATIONS
SE7706877L (en) CHEMICAL INTERMEDIATES
NO834146L (en) PROCEDURE FOR THE PREPARATION OF EPIMERT AZAHOMOERYTROMYCIN A
ES499485A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF CEPHALOSPO-RINA
SE7611047L (en) PROCEDURE FOR PREPARING ANTIBACTERIAL SUBJECT
ES408972A1 (en) A PROCEDURE FOR THE PREPARATION OF A CEPHALOS-PORINE COMPOUND.
SE7704301L (en) ANTIBIOTICS
EP0196628A3 (en) Ansamycin antibioticum, microbiological process for its preparation and its use as a medicament
SE7612962L (en) TIENAMYCIN DERIVATIVES
ES436103A1 (en) A PROCEDURE FOR THE PREPARATION OF ANTIBIOTICS.
SE7508570L (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE ASSOCIATIONS
IL35875A (en) Pharmaceutical compositions for the treatment of microbial infections containing an n-(3-carboxy-propionyl)glutamic acid derivative
ES8105147A1 (en) Pharmaceutical compositions endowed with an antibacterial activity and their use in the treatment of infections due to gram-positive and gram-negative pathogens
SE7909501L (en) Cephalosporin antibiotics
JPS54154785A (en) Cephem derivative and its manufacture
GB1531141A (en) Beta-lactam antibiotics
SE7612963L (en) TIENAMYCIN DERIVATIVES
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
GB1470329A (en) Antibiotic derivatives of xk-62-2 and method of production thereof
GB1504589A (en) Substituted cephalosporin antibiotics
SE7612960L (en) TIENAMYCIN DERIVATIVES
SE7712645L (en) MONOCYCLIC BETA LACTAMS WITH ANTIBACTERIAL ACTIVITY
SE7707366L (en) PROCEDURE FOR THE PREPARATION OF 7ALFA-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612295-1

Format of ref document f/p: F